Latest / Stock Movers / Fox Rises, Pfizer Higher, Kenvue Falls As Trump Admin to Links Tylenol to Autism.
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg data.
- 0:16Speaker 1: Let's take a look at some of the stocks on
- 0:18Speaker 1: the move that I am Paul Sweeney alongside Scarlett Fooh,
- 0:20Speaker 1: and we're joined by Bloomberg, Christina, Quino Phi Christine.
- 0:23Speaker 2: What are you have first?
- 0:23Speaker 1: Today? Let's look at Fox, shall we so ticker Fox?
- 0:26Speaker 1: Those shares are up today one point nine percent, and
- 0:29Speaker 1: that is because there is some suggestion from President Donald
- 0:32Speaker 1: Trump that Fox chairman Lachlan Murdock and his father Rupert
- 0:36Speaker 1: are involved in this TikTok deal. Now we know from
- 0:39Speaker 1: the White House official announcement on Saturday that the use
- 0:42Speaker 1: operations of TikTok will be majority owned and controlled by
- 0:45Speaker 1: American investors, which includes Oracle. Now Oracle has seen the
- 0:49Speaker 1: benefit of being involved in this TikTok deal. Last week
- 0:52Speaker 1: it was doing monster numbers in terms of the stock games.
- 0:55Speaker 1: But now potentially if there is some kind of Fox
- 0:59Speaker 1: family involved moment, then maybe that's a boost those shares
- 1:03Speaker 1: as well. Bloomerre Intelligence weighing in and saying that ownership
- 1:05Speaker 1: in TikTok could give Fox a foothold in social media
- 1:09Speaker 1: because now linear TV is facing secular challenges, so good
- 1:13Speaker 1: time for them.
- 1:13Speaker 2: It's eternally facing secular challenges.
- 1:16Speaker 1: Pfizer of course on the horizon too, and some M
- 1:20Speaker 1: and A news. Yeah, absolutely scarless of Pfizer ticker PFE.
- 1:24Speaker 1: Those shares are soaring two point nine percent at the moment.
- 1:28Speaker 1: And you know, we know that they're going to be
- 1:29Speaker 1: paying four nine billion dollars for this obesity drug startup
- 1:33Speaker 1: met Sarah because they do want to catch up to
- 1:37Speaker 1: their rivals in that obesity drug game. So here's the
- 1:40Speaker 1: kicker for the deal though. So basically they're agreeing to
- 1:43Speaker 1: buy met Sarah for forty seven to fifty in cash
- 1:45Speaker 1: per share, and then the deal also includes further payments
- 1:49Speaker 1: of up to twenty two fifty per share if there
- 1:51Speaker 1: are specific and regulatory milestones that are met. So potentially
- 1:56Speaker 1: that deal could total seven point three billion dollars. And
- 1:59Speaker 1: so were intelligence analysts saying that this is a good
- 2:02Speaker 1: thing for Pfizer. The deal could potentially catapult them up
- 2:06Speaker 1: the obesity ladder because it provides them access to injections
- 2:10Speaker 1: that are highly competitive in terms that our profiled.
- 2:13Speaker 2: Right, We'll have Sam Fazzelli from Bloomberg Intelligence on later
- 2:16Speaker 2: this hour to break down the steal.
- 2:17Speaker 1: One more. Let's take a look at Kenview. So Tigger
- 2:20Speaker 1: k the ue, those chares not doing the hot at
- 2:23Speaker 1: the moment, down more than five percent now, and that's
- 2:25Speaker 1: because we did get a Washington Post report over do
- 2:28Speaker 1: we can say that Trump administration officials plan to link
- 2:32Speaker 1: the active ingredient in time law, which is made by Canview,
- 2:35Speaker 1: to autism. So that's expected to come today. The Post
- 2:38Speaker 1: reporting this and citing unnamed people familiar with the matter,
- 2:42Speaker 1: so you know, Bloomery Intelligence saying that if there is
- 2:45Speaker 1: any reduced amount for tilnol as a result of this,
- 2:48Speaker 1: then that will make their return to EPs growth this
- 2:52Speaker 1: next year more challenging because they're already facing autism related
- 2:55Speaker 1: lawsuits because of this, So this is just another.
- 2:57Speaker 2: Problem they go to drug from me of things everywhere.
- 3:02Speaker 2: The Stockmover's report from Bloomberg Radio. Check back with us
- 3:06Speaker 2: throughout the day for the latest roundup of companies making
- 3:09Speaker 2: news on Wall Street and for the latest market moving headlines.
- 3:13Speaker 2: Listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg
- 3:17Speaker 2: dot com and on Applecarplay and Android Auto with the
- 3:20Speaker 2: Bloomberg Business App